Invention Grant
- Patent Title: Interferon therapy
-
Application No.: US15430456Application Date: 2017-02-11
-
Publication No.: US10335461B2Publication Date: 2019-07-02
- Inventor: Nigel Parker
- Applicant: FKD Therapies Limited
- Applicant Address: GB Chinnor
- Assignee: Trizell Limited
- Current Assignee: Trizell Limited
- Current Assignee Address: GB Chinnor
- Agency: Pharmaceutical Patent Attorneys, LLC
- Main IPC: A61K38/21
- IPC: A61K38/21 ; A61K39/00 ; A61K39/02 ; A61K39/12 ; A61K39/39 ; A61K39/395 ; A61K48/00 ; C07K16/30 ; A61K47/60 ; C07K16/28 ; A61P35/00 ; C12N15/86
Abstract:
Interferon therapy is improved by concomitant administration of an agent which minimizes the ability of interferon to up-regulate expression of Programmed Cell Death Protein 1 (also known as CD279).
Public/Granted literature
- US20170232071A1 Interferon Therapy Public/Granted day:2017-08-17
Information query
IPC分类:
